XILIO THERAPEUTICS INC. - COMMON STOCK
0.7718
13-مارس-25 12:04:26
15 متأخرة بدقائق
الأسهم
-0.0532
-6.45%
نطاق اليوم
0.7718 - 0.8247
ISIN
N/A
المصدر
NASDAQ
-
Xilio Therapeutics to Present at the Citi 2023 Virtual Oncology Leadership Summit
16 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
02 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Host Live Virtual Program Spotlighting XTX301, a Tumor-Activated IL-12
23 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
09 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Cowen 6th Annual ‘IO Next’ Summit
04 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference
22 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Tomas J. Heyman to Board of Directors
15 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
16 يونيو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the H.C. Wainwright Global Investment Conference
18 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
17 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
12 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
07 أبريل 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
01 مارس 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Cowen 42nd Annual Healthcare Conference
28 فبراير 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics to Participate in the Guggenheim 4th Annual Oncology Day
03 فبراير 2022 06:30:00 بحسب Nasdaq GlobeNewswire
-
20 يناير 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
06 يناير 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Xilio Therapeutics Reports Pipeline and Business Progress and Third Quarter 2021 Financial Results
02 ديسمبر 2021 07:30:00 بحسب Nasdaq GlobeNewswire